Prostate Cancer — Proceedings from the 2025 Annual ONS Congress
Dr Rahul Aggarwal and Dr William K Oh and nurse practitioners Ms Monica Averia and Ms Kathleen D Burns discuss the current treatment landscape for prostate cancer and protocols to mitigate and manage treatment-emergent adverse events.
NCPD information and select publications here (https://www.researchtopractice.com/ONS2025/Prostate) .
Видео Prostate Cancer — Proceedings from the 2025 Annual ONS Congress канала Research To Practice
NCPD information and select publications here (https://www.researchtopractice.com/ONS2025/Prostate) .
Видео Prostate Cancer — Proceedings from the 2025 Annual ONS Congress канала Research To Practice
Комментарии отсутствуют
Информация о видео
9 мая 2025 г. 3:01:03
01:27:51
Другие видео канала
What I Tell My Patients: Hormonal Therapy for Hormone Receptor-Positive Breast Cancer
Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
Antibody-Drug Conjugates in the Management of HR+ and Triple-Negative Metastatic Breast Cancer
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology...
IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management...
Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings fro...
Immunotherapy and Other Nontargeted Approaches for NSCLC @ 4th Annual National GMO Summit
Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations ...
Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 5
Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
Current and Future Role of Immunotherapy and Antibody-Drug Conjugates in Lung Cancer
Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Mee...
Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
Hormone Receptor-Positive Breast Cancer | Erica Mayer, MD, MPH, FASCO
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR ...
Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies
